Nrf2 activators have been reported as contributing to the fight against several pathologic conditions, such as diabetes, Alzheimer disease, cardiovascular disease, diabetic foot ulcer and diabetic nephropathy. The gene discussed is NFE2L2; the disease is diabetic kidney disease.